$USM
UNITED STATES CELLULAR CORP

2021 Q1 Form 10-Q Financial Statement

#000082113021000026 Filed on May 06, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $1.023B $963.0M
YoY Change 6.23% -0.31%
Cost Of Revenue $460.0M $397.0M
YoY Change 15.87% -2.93%
Gross Profit $563.0M $566.0M
YoY Change -0.53% 1.62%
Gross Profit Margin 55.03% 58.77%
Selling, General & Admin $305.0M $335.0M
YoY Change -8.96% 2.76%
% of Gross Profit 54.17% 59.19%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $170.0M $177.0M
YoY Change -3.95% 4.73%
% of Gross Profit 30.2% 31.27%
Operating Expenses $939.0M $913.0M
YoY Change 2.85% 1.22%
Operating Profit $84.00M $50.00M
YoY Change 68.0% -21.88%
Interest Expense $39.00M $24.00M
YoY Change 62.5% -17.24%
% of Operating Profit 46.43% 48.0%
Other Income/Expense, Net $5.000M $26.00M
YoY Change -80.77% 23.81%
Pretax Income $89.00M $76.00M
YoY Change 17.11% -10.59%
Income Tax $27.00M $4.000M
% Of Pretax Income 30.34% 5.26%
Net Earnings $60.00M $71.00M
YoY Change -15.49% 31.48%
Net Earnings / Revenue 5.87% 7.37%
Basic Earnings Per Share $0.70 $0.82
Diluted Earnings Per Share $0.69 $0.81
COMMON SHARES
Basic Shares Outstanding 86.00M shares 86.00M shares
Diluted Shares Outstanding 88.00M shares 88.00M shares

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $482.0M $258.0M
YoY Change 86.82% -61.2%
Cash & Equivalents $479.0M $258.0M
Short-Term Investments $3.000M
Other Short-Term Assets $43.00M $22.00M
YoY Change 95.45% -24.14%
Inventory $139.0M $212.0M
Prepaid Expenses $63.00M $58.00M
Receivables $900.0M $865.0M
Other Receivables $209.0M $136.0M
Total Short-Term Assets $1.845B $1.576B
YoY Change 17.07% -14.3%
LONG-TERM ASSETS
Property, Plant & Equipment $2.419B $2.268B
YoY Change 6.66% 6.13%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $447.0M $461.0M
YoY Change -3.04% 0.22%
Other Assets $580.0M $534.0M
YoY Change 8.61% -5.82%
Total Long-Term Assets $8.303B $6.675B
YoY Change 24.39% 4.46%
TOTAL ASSETS
Total Short-Term Assets $1.845B $1.576B
Total Long-Term Assets $8.303B $6.675B
Total Assets $10.15B $8.251B
YoY Change 22.99% 0.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $282.0M $328.0M
YoY Change -14.02% -9.89%
Accrued Expenses $207.0M $183.0M
YoY Change 13.11% 4.57%
Deferred Revenue $158.0M $139.0M
YoY Change 13.67%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $2.000M $6.000M
YoY Change -66.67% -68.42%
Total Short-Term Liabilities $739.0M $722.0M
YoY Change 2.35% -9.98%
LONG-TERM LIABILITIES
Long-Term Debt $2.981B $1.503B
YoY Change 98.34% -6.12%
Other Long-Term Liabilities $393.0M $327.0M
YoY Change 20.18% 11.99%
Total Long-Term Liabilities $393.0M $327.0M
YoY Change 20.18% 11.99%
TOTAL LIABILITIES
Total Short-Term Liabilities $739.0M $722.0M
Total Long-Term Liabilities $393.0M $327.0M
Total Liabilities $1.132B $1.049B
YoY Change 7.91% -4.11%
SHAREHOLDERS EQUITY
Retained Earnings $2.796B $2.620B
YoY Change 6.72% 4.93%
Common Stock $88.00M $88.00M
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $66.00M $92.00M
YoY Change -28.26% 46.03%
Treasury Stock Shares
Shareholders Equity $4.475B $4.252B
YoY Change
Total Liabilities & Shareholders Equity $10.15B $8.251B
YoY Change 22.99% 0.27%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income $60.00M $71.00M
YoY Change -15.49% 31.48%
Depreciation, Depletion And Amortization $170.0M $177.0M
YoY Change -3.95% 4.73%
Cash From Operating Activities $124.0M $342.0M
YoY Change -63.74% 19.16%
INVESTING ACTIVITIES
Capital Expenditures -$1.389B -$341.0M
YoY Change 307.33% 215.74%
Acquisitions
YoY Change
Other Investing Activities $1.000M $0.00
YoY Change -100.0%
Cash From Investing Activities -$1.388B -$342.0M
YoY Change 305.85% 61.32%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $2.000M $21.00M
YoY Change -90.48%
Debt Paid & Issued, Net $0.00 $2.000M
YoY Change -100.0% -60.0%
Cash From Financing Activities $485.0M -$24.00M
YoY Change -2120.83% 300.0%
NET CHANGE
Cash From Operating Activities $124.0M $342.0M
Cash From Investing Activities -$1.388B -$342.0M
Cash From Financing Activities $485.0M -$24.00M
Net Change In Cash -$779.0M -$24.00M
YoY Change 3145.83% -134.78%
FREE CASH FLOW
Cash From Operating Activities $124.0M $342.0M
Capital Expenditures -$1.389B -$341.0M
Free Cash Flow $1.513B $683.0M
YoY Change 121.52% 72.91%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000821130
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P9M
CY2021Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2021Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q1 dei Entity File Number
EntityFileNumber
001-09712
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
UNITED STATES CELLULAR CORPORATION
CY2021Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
CY2021Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Chicago
CY2021Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
62-1147325
CY2021Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
8410 West Bryn Mawr
CY2021Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60631
CY2021Q1 dei City Area Code
CityAreaCode
(773)
CY2021Q1 dei Local Phone Number
LocalPhoneNumber
399-8900
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q1 us-gaap Revenues
Revenues
1023000000 USD
CY2020Q1 us-gaap Revenues
Revenues
963000000 USD
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
305000000 USD
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
335000000 USD
CY2021Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
170000000 USD
CY2020Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
177000000 USD
CY2021Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-5000000 USD
CY2020Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-4000000 USD
CY2021Q1 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
1000000 USD
CY2020Q1 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 USD
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
939000000 USD
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
913000000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
84000000 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
50000000 USD
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
42000000 USD
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
45000000 USD
CY2021Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
2000000 USD
CY2020Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
4000000 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
39000000 USD
CY2020Q1 us-gaap Interest Expense
InterestExpense
24000000 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000000 USD
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5000000 USD
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
26000000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
89000000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
76000000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27000000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4000000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
62000000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
72000000 USD
CY2021Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2000000 USD
CY2020Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
60000000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
71000000 USD
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
86000000 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
86000000 shares
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.70
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.82
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
88000000 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
88000000 shares
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.69
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.81
CY2021Q1 us-gaap Profit Loss
ProfitLoss
62000000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
72000000 USD
CY2021Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
170000000 USD
CY2020Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
177000000 USD
CY2021Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
7000000 USD
CY2020Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
33000000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
6000000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
7000000 USD
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
23000000 USD
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
52000000 USD
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
42000000 USD
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
45000000 USD
CY2021Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
22000000 USD
CY2020Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
24000000 USD
CY2021Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-5000000 USD
CY2020Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-4000000 USD
CY2021Q1 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
1000000 USD
CY2020Q1 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 USD
CY2021Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-1000000 USD
CY2020Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
0 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4000000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-55000000 USD
CY2021Q1 us-gaap Increase Decrease In Finance Receivables
IncreaseDecreaseInFinanceReceivables
18000000 USD
CY2020Q1 us-gaap Increase Decrease In Finance Receivables
IncreaseDecreaseInFinanceReceivables
-23000000 USD
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-7000000 USD
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
50000000 USD
CY2021Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-86000000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
97000000 USD
CY2021Q1 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
7000000 USD
CY2020Q1 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-10000000 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
3000000 USD
CY2020Q1 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
-49000000 USD
CY2021Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
9000000 USD
CY2020Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
9000000 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
53000000 USD
CY2020Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
57000000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
124000000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
342000000 USD
CY2021Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
133000000 USD
CY2020Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
315000000 USD
CY2021Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1256000000 USD
CY2020Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
26000000 USD
CY2020Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
1000000 USD
CY2021Q1 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
1000000 USD
CY2020Q1 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1388000000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-342000000 USD
CY2021Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
492000000 USD
CY2020Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
CY2021Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
CY2020Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2000000 USD
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1000000 USD
CY2020Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 USD
CY2021Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2000000 USD
CY2020Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
21000000 USD
CY2021Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1000000 USD
CY2020Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1000000 USD
CY2021Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
1000000 USD
CY2020Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
1000000 USD
CY2021Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-2000000 USD
CY2020Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
1000000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
485000000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-24000000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-779000000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-24000000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1291000000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
291000000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
512000000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
267000000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
479000000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1271000000 USD
CY2021Q1 us-gaap Short Term Investments
ShortTermInvestments
3000000 USD
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
3000000 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
56000000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
62000000 USD
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
900000000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
915000000 USD
CY2021Q1 usm Receivables Net Current Roaming
ReceivablesNetCurrentRoaming
9000000 USD
CY2020Q4 usm Receivables Net Current Roaming
ReceivablesNetCurrentRoaming
13000000 USD
CY2021Q1 us-gaap Allowance For Doubtful Other Receivables Current
AllowanceForDoubtfulOtherReceivablesCurrent
2000000 USD
CY2020Q4 us-gaap Allowance For Doubtful Other Receivables Current
AllowanceForDoubtfulOtherReceivablesCurrent
1000000 USD
CY2021Q1 us-gaap Other Receivables
OtherReceivables
85000000 USD
CY2020Q4 us-gaap Other Receivables
OtherReceivables
70000000 USD
CY2021Q1 us-gaap Inventory Net
InventoryNet
139000000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
146000000 USD
CY2021Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
63000000 USD
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
51000000 USD
CY2021Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
124000000 USD
CY2020Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
125000000 USD
CY2021Q1 us-gaap Other Assets Current
OtherAssetsCurrent
43000000 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
1845000000 USD
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
29000000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
2623000000 USD
CY2021Q1 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
1000000 USD
CY2020Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
2000000 USD
CY2021Q1 us-gaap Indefinite Lived License Agreements
IndefiniteLivedLicenseAgreements
3915000000 USD
CY2020Q4 us-gaap Indefinite Lived License Agreements
IndefiniteLivedLicenseAgreements
2629000000 USD
CY2021Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
455000000 USD
CY2020Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
435000000 USD
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8823000000 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8785000000 USD
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6404000000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6319000000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2419000000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2466000000 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
933000000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
924000000 USD
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
580000000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
602000000 USD
CY2021Q1 us-gaap Assets
Assets
10148000000 USD
CY2020Q4 us-gaap Assets
Assets
9681000000 USD
CY2021Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
2000000 USD
CY2020Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
2000000 USD
CY2021Q1 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
6000000 USD
CY2020Q4 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
10000000 USD
CY2021Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
276000000 USD
CY2020Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
377000000 USD
CY2021Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
158000000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
151000000 USD
CY2021Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
47000000 USD
CY2020Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
48000000 USD
CY2021Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
40000000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
82000000 USD
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
120000000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
116000000 USD
CY2021Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
90000000 USD
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
85000000 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
739000000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
871000000 USD
CY2021Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
0 USD
CY2020Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
1000000 USD
CY2021Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
656000000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
633000000 USD
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
879000000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
875000000 USD
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
393000000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
376000000 USD
CY2021Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
2981000000 USD
CY2020Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
2489000000 USD
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q1 us-gaap Redeemable Noncontrolling Interest Equity Other Carrying Amount
RedeemableNoncontrollingInterestEquityOtherCarryingAmount
10000000 USD
CY2020Q4 us-gaap Redeemable Noncontrolling Interest Equity Other Carrying Amount
RedeemableNoncontrollingInterestEquityOtherCarryingAmount
10000000 USD
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
190000000 shares
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
190000000 shares
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
88000000 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
88000000 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
86000000 shares
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
86000000 shares
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
88000000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
88000000 USD
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1657000000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1651000000 USD
CY2021Q1 us-gaap Treasury Stock Value
TreasuryStockValue
66000000 USD
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
67000000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2796000000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2739000000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
4475000000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
4411000000 USD
CY2021Q1 us-gaap Minority Interest
MinorityInterest
15000000 USD
CY2020Q4 us-gaap Minority Interest
MinorityInterest
15000000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4490000000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4426000000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10148000000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9681000000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4426000000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
60000000 USD
CY2021Q1 usm Minority Interest In Net Income Loss Equity Minority Interests
MinorityInterestInNetIncomeLossEquityMinorityInterests
1000000 USD
CY2021Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
2000000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
6000000 USD
CY2021Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
1000000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4490000000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4210000000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
71000000 USD
CY2020Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
23000000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7000000 USD
CY2020Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
1000000 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4264000000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
479000000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1271000000 USD
CY2021Q1 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
33000000 USD
CY2020Q4 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
20000000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
512000000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1291000000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1003000000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
944000000 USD
CY2021Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
20000000 USD
CY2020Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
19000000 USD
CY2021Q1 us-gaap Revenues
Revenues
1023000000 USD
CY2020Q1 us-gaap Revenues
Revenues
963000000 USD
CY2021Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
11000000 USD
CY2020Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
10000000 USD
CY2021Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
185000000 USD
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
171000000 USD
CY2021Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
97000000 USD
CY2021Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
1013000000 USD
CY2020Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
1007000000 USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
72000000 USD
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
78000000 USD
CY2021Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
209000000 USD
CY2021Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
112000000 USD
CY2021Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
128000000 USD
CY2021Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
449000000 USD
CY2021Q1 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
123000000 USD
CY2020Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
124000000 USD
CY2021Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
25000000 USD
CY2020Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
27000000 USD
CY2021Q1 us-gaap Notes Receivable Net
NotesReceivableNet
941000000 USD
CY2020Q4 us-gaap Notes Receivable Net
NotesReceivableNet
929000000 USD
CY2021Q1 us-gaap Notes Receivable Net
NotesReceivableNet
941000000 USD
CY2020Q4 us-gaap Notes Receivable Net
NotesReceivableNet
929000000 USD
CY2021Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
1013000000 USD
CY2020Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
1007000000 USD
CY2021Q1 us-gaap Financing Receivable Originated Three Years Before Latest Fiscal Year
FinancingReceivableOriginatedThreeYearsBeforeLatestFiscalYear
17000000 USD
CY2021Q1 us-gaap Financing Receivable Originated Two Years Before Latest Fiscal Year
FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear
224000000 USD
CY2021Q1 us-gaap Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year
FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear
562000000 USD
CY2021Q1 us-gaap Financing Receivable Originated In Current Fiscal Year
FinancingReceivableOriginatedInCurrentFiscalYear
210000000 USD
CY2021Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
1013000000 USD
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.304
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.050
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
60000000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
71000000 USD
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
86000000 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
86000000 shares
CY2021Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2000000 shares
CY2020Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2000000 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
88000000 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
88000000 shares
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.70
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.82
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.69
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.81
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1000000 shares
CY2020Q4 us-gaap Indefinite Lived License Agreements
IndefiniteLivedLicenseAgreements
2629000000 USD
CY2021Q1 us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
1283000000 USD
CY2021Q1 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
3000000 USD
CY2021Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
3915000000 USD
CY2021Q1 us-gaap Equity Method Investments
EquityMethodInvestments
447000000 USD
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
428000000 USD
CY2021Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
8000000 USD
CY2020Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
7000000 USD
CY2021Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
455000000 USD
CY2020Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
435000000 USD
CY2021Q1 us-gaap Variable Interest Entity Entity Maximum Loss Exposure Amount
VariableInterestEntityEntityMaximumLossExposureAmount
5000000 USD
CY2020Q4 us-gaap Variable Interest Entity Entity Maximum Loss Exposure Amount
VariableInterestEntityEntityMaximumLossExposureAmount
5000000 USD
CY2021Q1 us-gaap Variable Interest Entity Financial Or Other Support Amount
VariableInterestEntityFinancialOrOtherSupportAmount
30000000 USD
CY2020Q1 us-gaap Variable Interest Entity Financial Or Other Support Amount
VariableInterestEntityFinancialOrOtherSupportAmount
69000000 USD

Files In Submission

Name View Source Status
0000821130-21-000026-index-headers.html Edgar Link pending
0000821130-21-000026-index.html Edgar Link pending
0000821130-21-000026.txt Edgar Link pending
0000821130-21-000026-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
usm-20210331.htm Edgar Link pending
usm-20210331.xsd Edgar Link pending
usm-20210331_cal.xml Edgar Link unprocessable
usm-20210331_def.xml Edgar Link unprocessable
usm-20210331_g1.jpg Edgar Link pending
usm-20210331_g2.jpg Edgar Link pending
usm-20210331_g3.jpg Edgar Link pending
usm-20210331_g4.jpg Edgar Link pending
usm-20210331_g5.jpg Edgar Link pending
usm-20210331_g6.jpg Edgar Link pending
usm-20210331_g7.jpg Edgar Link pending
usm-20210331_htm.xml Edgar Link completed
usm-20210331_lab.xml Edgar Link unprocessable
usm-20210331_pre.xml Edgar Link unprocessable
usm331202110-qex101.htm Edgar Link pending
usm3312021ex311.htm Edgar Link pending
usm3312021ex312.htm Edgar Link pending
usm3312021ex321.htm Edgar Link pending
usm3332021ex322.htm Edgar Link pending